Previous 10 | Next 10 |
Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
BMS reports Q4 and guides for 2019 Bristol-Myers Squibb ( BMY ) reported Q4 and full-year results last week. Revenues were $6 B, up 10% (12% adjusted for currency). R&D was $1.4 B, 23% of revenues, well above the 15% that stalwarts such as Pfizer ( PFE ) and Merck ( MRK ) typically run...
AbbVie slammed again - is it 'piling on' now? Before getting into the details, it's worth thinking about AbbVie's ( ABBV ) ups and downs the past 5 years (semi-log scale): Data by YCharts Two points: first, just a guess that if YCharts provided a regression line, ABBV around $80 would ...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, loo...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Mega-cap tech companies Apple (AAPL), Microsoft (MSFT), Facebook, (FB), Alibaba (BA...
As the government shutdown becomes the longest on record, most offices, including the Food and Drug Administration, are below operating capacity. This, of course, directly affects the health care sector. It has understandably been hampering new drug efforts, leading to the FDA to not accept pr...
NEW YORK, NY / ACCESSWIRE / January 24, 2019 / U.S. equities regained its footing on Wednesday on the back of strong corporate earnings. Overall profits of the companies who have reported quarterly results so far have risen by approximately by 13.2 percent. The Dow Jones Industrial Average c...
Jefferies healthcare strategist Jared Holtz is a short-term biotech bear saying that profit-taking "makes sense" through this earnings season considering the sector's market-leading performance so far this year. He thinks the SPDR S&P Biotech ETF ( XBI -1.3% ) could drop to $75 ( -6% )...
Introduction Relying on dividend income to meet the financial needs of retirement is my vision for a healthy and stable retirement. To achieve the level of dividend income needed to cover most living expenses, a savings and investing plan is required. I call my plan RetirementRx . Retirem...
Privately held Swiss-Italian biotech Philogen S.p.A. has been active in adding to its lineup of collaborators. More news on: Novartis AG, Johnson & Johnson, Celgene Corporation, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Celgene Corporation Company Name:
CELG Stock Symbol:
NASDAQ Market:
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributor Brian Orelli analyzes Gilead 's (NASDAQ: GILD) earnings report and discusses why the biotech giant could see fairly low revenue growth or even see earnings dr...
What coronavirus? Amgen 's (NASDAQ: AMGN) latest set of quarterly figures, delivered Tuesday, showed growth in the company's fundamentals during a challenging time for companies across all economic sectors. The veteran biotech company booked revenue of nearly $6.21 billion in the second qu...
It's scary out there right now for investors, with wild market swings and a lot of negative news coming out of quarterly reports. There is one sector, however, that will survive and likely thrive despite the coronavirus pandemic shutdown -- healthcare. That said, investors shouldn't head for jus...